Epidemiological profile of cervical cancer in Brazil and its regions in the period 2018 and 2022
PDF (Português (Brasil))

Keywords

Brazil
Epidemiolgy
Uterine Cervical Neoplasms

How to Cite

Freitas, I. A. S., Cavalcante, A. F. C., Melo Júnior, F. A. F. de, Bulgo, D. C., Sousa Filho, F. C. de, Sousa, G. P. de, Lara, G. R. de, Moura, M. C. R., Nascimento, K. . S. do, & Ferreira, J. G. H. (2023). Epidemiological profile of cervical cancer in Brazil and its regions in the period 2018 and 2022. Brazilian Journal of Implantology and Health Sciences, 5(4), 1710–1719. https://doi.org/10.36557/2674-8169.2023v5n4p1710-1719

Abstract

Cervical cancer is the fourth most common malignancy in women, with an estimated worldwide incidence of 595,414 new cases and mortality of 311,365 women in 2018. This is a cross-sectional descriptive study, with a documentary approach, through secondary data collected in the Department of Informatics of the Unified Health System. In short, it can be summarized that the profile of the most affected pediatric population was women between 40 and 49 years old, from the Southeast region and of brown ethnicity, and the year of greatest involvement was 2022. With this, it is possible to point out hospitalizations for Malignant Neoplasia of the Cervix, in Brazilian women, as a public health problem that deserves the attention of the government and Brazilian society in general.

https://doi.org/10.36557/2674-8169.2023v5n4p1710-1719
PDF (Português (Brasil))

References

ABU-RUSTUM, N. R. et al. NCCN Guidelines Insights: Cervical Cancer, Version 1.2020. Journal of the National Comprehensive Cancer Network, v. 18, n. 6, p. 660–666, jun. 2020.

BARCELOS, M. R. B. et al. Quality of cervical cancer screening in Brazil: external assessment of the PMAQ. Revista de Saúde Pública, v. 51, n. 0, 20 jul. 2017.

BHATLA, N. et al. Revised FIGO staging for carcinoma of the cervix uteri. International Journal of Gynecology & Obstetrics, v. 145, n. 1, p. 129–135, 17 jan. 2019.

BRAY, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians, v. 68, n. 6, p. 394–424, 12 set. 2018.

CERQUEIRA, R. S. et al. Controle do câncer do colo do útero na atenção primária à saúde em países sul-americanos: revisão sistemática. Revista Panamericana de Salud Pública, v. 46, p. 1, 18 ago. 2022.

DATASUS – Ministério da Saúde. Disponível em: <https://datasus.saude.gov.br/>. Acesso em: 25 jun. 2023.

FENG, Y. et al. The safety of fertility preservation for microinvasive cervical adenocarcinoma: a meta-analysis and trial sequential analysis. Archives of Gynecology and Obstetrics, v. 298, n. 3, p. 465–475, 6 jun. 2018.

GAVINSKI, K.; DINARDO, D. Cervical Cancer Screening. Medical Clinics of North America, dez. 2022.

Instituto Nacional de Cancer José Alencar Gomes da Silva (INCA). Estimativa 2020: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2020. Disponível em: https://www.inca.gov.br/publicacoes/livros/estimativa-2020-incidencia-de-cancer-no-brasil. Acesso em: 26 ago. 2023.

LOPES, V. A. S.; RIBEIRO, J. M. Fatores limitadores e facilitadores para o controle do câncer de colo de útero: uma revisão de literatura. Ciência & Saúde Coletiva, v. 24, p. 3431–3442, 5 set. 2019.

MEDRONHO, R. Epidemiologia. 2ª edição. São Paulo, 2009.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Igor Aser Sousa Freitas, Amanda Farias Caiaffo Cavalcante, Fernando Antônio Fernandes de Melo Júnior, Danilo Cândido Bulgo, Fernando Cesar de Sousa Filho, Giovana Pereira de Sousa, Gabriela Ribeiro de Lara, Maria Clara Rodrigues Moura, Karyna Santana do Nascimento, Juliana Gervasi Heidgger Ferreira